Researchers who work with materials such as fetal tissue and human embryonic stem cells are facing new restrictions, the latest in a long line of regulations, that could impede important advances.
After lobbying efforts from lawmakers and science advisors, the new, DARPA-like biomedical research agency will be a part of the National Institutes of Health, but its director will report directly to the secretary of Health and Human Services.
Geneticist Terry Magnuson steps down as vice-chancellor at the University of North Carolina at Chapel Hill after he copied text from multiple sources he found online into a grant application.
The legislation, which now heads to the House, aims to ensure the country can compete with China technologically by supporting research and development over the next five years.
Ronald Davis of Stanford University changed his focus to research on ME/CFS, the disease formerly known as chronic fatigue syndrome, in a bid to help his son and others like him.
More than 3,000 researchers have signed on to a petition that expresses concern over the agency’s 2021 application for the funding program, which emphasizes three areas of computational science and might further disadvantage underrepresented groups.
Rick Bright will no longer head the Biomedical Advanced Research and Development Authority and will instead work at the National Institutes of Health on diagnostics for SARS-CoV-2 infection.
A program to encourage transdisciplinary research at top cancer centers has evolved into a counterproductive national strategy for organizing cancer research.
It’s unclear how the order, which charges academic institutions to follow existing rules regarding the First Amendment, will be implemented and enforced.
